Latest News
September 02, 2010
Doctors from Jefferson Medical College of Thomas Jefferson University have written and published a new, comprehensive guide on heart care titled: Jefferson Heart Institute Handbook of Cardiology. The medical textbook is geared toward medical students, residents and fellows, internists and cardiologists, offering a concise guide of cardiac disorders and how to treat them. The book will be available in September, 2010.
August 27, 2010
Scientists at Jefferson Medical College have received a four-year, $3 million National Institutes of Health grant funded by the National Heart, Lung and Blood Institute to study variations of platelet function, specifically, the genetics of platelet gene expression. The study aims to find data that can be translated into novel therapeutic strategies and develop better predictors of cardiovascular disease.
August 19, 2010
Orthopedic surgeon John A. Abraham, M.D., has joined the Rothman Institute at Jefferson. He has also been named an assistant professor of Orthopedic Surgery at Jefferson Medical College of Thomas Jefferson University and joins the faculty after serving for the past four years as a musculoskeletal oncology surgeon at the Dana-Farber Cancer Center at Harvard Medical School.
Featured August 11, 2010
A recent study found that the rare skin blistering disease epidermolysis bullosa may be treated by bone marrow stem cell transplant. Dr. Jouni Uitto, a dermatologist at Jefferson, says that "lessening of the severe blistering to any degree is good news to the patients and their families."
August 03, 2010
Robert H. Rosenwasser, M.D., F.A.C.S., F.A.H.A., professor and chair, Department of Neurological Surgery at Jefferson Medical College of Thomas Jefferson University; and co-director of the Stroke Program at Thomas Jefferson University Hospital has been named to the first endowed chair in the department’s history. This endowment honors the former chair, Jewell L. Osterholm, M.D., who led the department for two decades.
July 30, 2010
Physicians, scientists and research professionals at Thomas Jefferson University have created the Jefferson Coordinating Center for Clinical Research (JCCCR) in an effort to foster and promote excellence in clinical research. The enterprise will develop, initiate and participate in advanced clinical research funded by industry, nonprofit organizations and the US government. The JCCCR is an Academic Research Organization, a new organizational model allowing the coordination of research not just at the home academic medical institution, but with other partner organizations as well.
July 29, 2010
Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.
July 28, 2010
Physicians at Thomas Jefferson University’s Digestive Disease Institute are offering a pair of new pill capsule tests to help better diagnose and treat digestive tract disorders. While diagnosing and treating current patient’s illnesses are the most important aspect of these new capsule-based tests the physicians also hope to advance the technology far enough that one day the possibility of a pill capsule that can photograph and evaluate the function of the entire gastrointestinal tract will be possible.
July 15, 2010
Thomas Jefferson University Hospitals has again been ranked as the top hospital in Philadelphia for orthopaedics and rehabilitation medicine by U.S.News & World Report in their 2010 Best Hospitals survey. This ranking translates into the 13th best hospital in the nation for orthopaedic surgery and the 12th best in the U.S. for rehabilitation medicine.
Featured July 14, 2010
An ongoing clinical trial being conducted at Jefferson is testing whether high doses of vitamin C given through an IV can stop cancer cells from growing in patients who have advanced pancreatic cancer or non-Hodgkin's lymphoma. Dr. Monti of the Jefferson-Myrna Brind Center of Integrative Medicine who is behind the study, talks about the treatment to NBC 10.